Living donor liver transplantation in the USA
- PMID: 27115007
- PMCID: PMC4824744
- DOI: 10.3978/j.issn.2304-3881.2015.06.01
Living donor liver transplantation in the USA
Abstract
Living donor liver transplant (LDLT) accounts for a small volume of the transplants in the USA. Due to the current liver allocation system based on the model for end-stage liver disease (MELD), LDLT has a unique role in providing life-saving transplantation for patients with low MELD scores and significant complications from portal hypertension, as well as select patients with hepatocellular carcinoma (HCC). Donor safety is paramount and has been a topic of much discussion in the transplant community as well as the general media. The donor risk appears to be low overall, with a favorable long-term quality of life. The latest trend has been a gradual shift from right-lobe grafts to left-lobe grafts to reduce donor risk, provided that the left lobe can provide adequate liver volume for the recipient.
Keywords: Donor risk; left-lobe graft; liver transplantation; living donor; mortality.
Conflict of interest statement
Figures
References
-
- Strong RW, Lynch SV, Ong TH, et al. Successful liver transplantation from a living donor to her son. N Engl J Med 1990;322:1505-7. - PubMed
-
- Hashikura Y, Makuuchi M, Kawasaki S, et al. Successful living-related partial liver transplantation to an adult patient. Lancet 1994;343:1233-4. - PubMed
-
- Ben-Haim M, Emre S, Fishbein TM, et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient’s disease. Liver Transpl 2001;7:948-53. - PubMed
Publication types
LinkOut - more resources
Full Text Sources